Ceribell vs OpenEvidence

One is signed by a hospital and the other opened by an individual physician. Ceribell's terms run a one-year initial term that auto-renews unless the hospital gives 90 days' notice, with fees paid in advance and $2,500 reimbursable for a loaned recorder that is lost or destroyed. OpenEvidence is free to NPI-verified physicians and paid for by advertising, and its privacy banner says it shares limited information with third parties to measure advertising and does not sell or share searches.

OpenEvidence answers clinical questions with cited literature, and its security page states SOC 2 Type II and HIPAA compliance under a standard BAA. Ceribell's point-of-care EEG gives a hospital team a seizure burden estimate every 10 seconds, and the vendor's own figures for status epilepticus detection are 95% sensitivity and 97% specificity. The DECIDE multicenter prospective study of rapid-response EEG appeared in Critical Care Medicine in 2020. Physicians weigh OpenEvidence against UpToDate and Doximity GPT, while Ceribell's litigation is against the EEG competitor Natus, so the two sit on separate shortlists.